ATYR
aTyr Pharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ATYR Profile
Atyr Pharma, Inc.
A company that focused on researching the extracellular functionality and signaling pathways of tRNA synthetases
Biological Technology
09/08/2005
05/07/2015
NASDAQ Stock Exchange
56
12-31
Common stock
10240 Sorrento Valley Road, Suite 300, San Diego, CA 92121
--
ATyr Pharma, Inc., was incorporated in Delaware on September 8, 2005. The company is a clinical-stage biotechnology company that uses evolutionary intelligence to transform tRNA synthetase biology into new treatments for fibrosis and inflammation. TRNA synthetases are ancient, essential proteins that have evolved new domains to regulate different pathways outside the human cell. The company's discovery platform focuses on unlocking hidden therapeutic intervention points by discovering signaling pathways driven by domain proprietary libraries derived from all 20 tRNA synthetases.